
Camurus AB
STO:CAMX

Camurus AB
Operating Income
Camurus AB
Operating Income Peer Comparison



Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Camurus AB
STO:CAMX
|
Operating Income
kr236.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Calliditas Therapeutics AB
STO:CALTX
|
Operating Income
-kr396.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
![]() |
Orexo AB
STO:ORX
|
Operating Income
-kr57.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
S
|
Swedencare AB (publ)
STO:SECARE
|
Operating Income
kr224.5m
|
CAGR 3-Years
57%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
![]() |
IRLAB Therapeutics AB
STO:IRLAB A
|
Operating Income
-kr180.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
Operating Income
-kr238.9m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
See Also
What is Camurus AB's Operating Income?
Operating Income
236.8m
SEK
Based on the financial report for Jun 30, 2024, Camurus AB's Operating Income amounts to 236.8m SEK.
What is Camurus AB's Operating Income growth rate?
Operating Income CAGR 1Y
-54%
Over the last year, the Operating Income growth was -54%.